Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00477139 · ClinicalTrials.gov registry record

A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer

A clinical trial, sponsored by Stanford University.

Completed
Registry status
4
Enrollment target

NCT00477139: Completed study, sponsored by Stanford University.

NCT00477139 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00477139 has completed, sponsored by Stanford University.

COMPLETED
Registry status
4 participants
Enrollment target

Study Summary

This is a pilot study to gather preliminary data on the baseline immunologic status of patients with HER-2(+) breast cancer and to establish an immune monitoring laboratory for future clinical trial.

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2009-01
Est. Completion 2010-09
Stanford University

1,744 total trials

What the finished NCT00477139 record still lists

NCT00477139 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00477139 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00477139 about?

NCT00477139 is a clinical study titled "A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer". This is a pilot study to gather preliminary data on the baseline immunologic status of patients with HER-2(+) breast cancer and to establish an immune monitoring laboratory for future clinical trial.

What is the current status of trial NCT00477139?

This trial is currently completed. The enrollment target is 4 participants. The study started on 2009-01. Estimated completion is 2010-09.

Who is sponsoring clinical trial NCT00477139?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00477139, the US trial registry maintained by the National Library of Medicine. NCT00477139 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.